---
schema_version: "secwatch.filing_event.v1"
accession: "0001964738-25-000078"
form_type: "8-K"
ticker: "SOLV"
cik: "0001964738"
company_name: "Solventum Corp"
filed_at: "2025-09-02T23:59:59+00:00"
generated_at: "2026-05-17T09:00:08.811328+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Solventum completes $4.0B sale of Purification & Filtration business to Thermo Fisher

## Summary
- Completed sale of P&F business to Thermo Fisher for $4.0B cash on September 1, 2025.
- Net proceeds of $3.4B primarily to pay down outstanding debt; accelerates debt reduction.
- Updated FY2025 guidance: adjusted EPS raised to $5.88-$6.03 from $5.80-$5.95.
- Net interest expense now expected at $400M (down from $450M); operating margin toward 20%-21% high-end.
- Organic sales growth unchanged at +2.0% to +3.0%; free cash flow maintained at $450M-$550M.

## SEC filing metadata
- accession: 0001964738-25-000078
- form_type: 8-K
- ticker: SOLV
- cik: 0001964738
- company_name: Solventum Corp
- filed_at: 2025-09-02T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1964738/000196473825000078/0001964738-25-000078-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1964738/000196473825000078/solv-20250901.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001964738-25-000078
- JSON: https://secwatch.observer/filing/0001964738-25-000078.json
- Plain text: https://secwatch.observer/filing/0001964738-25-000078.txt

## Key facts
- M&A Transactions
  Solventum Corp completed a disposition involving Thermo Fisher Scientific Inc. for approximately $4.0 billion (closed 2025-09-01).
  - Action: disposition
  - Counterparty: Thermo Fisher Scientific Inc.
  - Consideration: approximately $4.0 billion
  - Closing: 2025-09-01
  source text: Solventum completed the sale of the Business to the Buyer in accordance with the terms of the Agreement. The cash consideration paid to Solventum at closing was approximately $4.0 billion, which is subject to further adjustments for closing cash and indebtedness, unpaid transaction expenses and working capital as set forth in the Agreement, as well as a payment to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1964738/000196473825000078/0001964738-25-000078-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.